Original Research
Published on 12 Nov 2018
Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment
in Drugs Outcomes Research and Policies
- 18,739 views
- 34 citations









